Statins use and prostate cancer mortality

The association between statins therapy and prostate cancer is extensively studied [1,2]. Recently, one cohort study conducted by Van Rompay et al. published in European Journal of Cancer demonstrated that statins use was associated with a lower mortality of prostate cancer than non-use (hazard ratio 0.73, 95% confidence interval 0.66–0.81) [3]. This result was compatible with another cohort study in Finland showing that statins use after prostate cancer diagnosis was associated with 20% reduced mortality of prostate cancer (hazard ratio 0.80, 95% confidence interval 0.65–0.98) [4].

Lascia un commento